Onasemnogene abeparvovec for treating spinal muscular atrophy
Highly specialised technologies guidance
Reference number: HST15
Published:
Last updated:
As you will be aware the last committee discussion for this evaluation was heard on Thursday 8 October 2020. A further committee discussion is now scheduled to take place on Wednesday 10th February 2021.